Today: 29 April 2026
Browse Category

NASDAQ:WVE 27 June 2025 - 8 December 2025

Biggest Stock Gainers Today: Biotech Breakouts and IBM–Confluent Deal Lead U.S. Market Movers (December 8, 2025)

Biggest Stock Gainers Today: Biotech Breakouts and IBM–Confluent Deal Lead U.S. Market Movers (December 8, 2025)

U.S. stocks were little changed Monday ahead of the Federal Reserve meeting, with the S&P 500 and Dow down 0.03% and the Nasdaq 100 up 0.07%. Small-cap stocks surged, led by biotech firms on clinical trial results and M&A news. Cemtrex soared 134%, Structure Therapeutics 97%, and Wave Life Sciences 92%. The Russell 2000 rose 0.55% intraday.
8 December 2025
········
Top Biotechnology and Health Tech Trends in 2025: Mid-Year Update and Forecast (Updated: June 27th, 2025)

Top Biotechnology and Health Tech Trends in 2025: Mid-Year Update and Forecast (Updated: June 27th, 2025)

The FDA approved Abeona’s Zevaskyn, the first cell-based gene therapy for RDEB, in April 2025, with launch set for Q3 at $3.1 million. Vertex’s CRISPR therapy Casgevy generated $2 million in Q3 2024. Novo Holdings acquired Catalent for $16.5 billion in January 2025 to secure GLP-1 drug manufacturing. Johnson & Johnson bought Intra-Cellular Therapies for $14.6 billion, expanding its neuroscience portfolio.
27 June 2025
···········
1 2

Stock Market Today

  • NXP Reports Record Q1 Profit and Revenue, Shares Surge 14%
    April 29, 2026, 6:05 AM EDT. NXP Semiconductors posted record Q1 profits of $1.22 billion, more than doubling from a year earlier, with revenue rising 12% to $3.18 billion. All four market segments grew, led by automotive and Industrial IoT, which surged 24% driven by automation and data centers. CEO Rafael Sotomayor highlighted strong demand for radar, connectivity chips, and smart robotics solutions. The company's stock soared 14% in after-hours trading, reflecting optimism over results surpassing Wall Street expectations. NXP forecasts Q2 revenue around $3.45 billion, an 18% increase, and adjusted earnings per share between $3.29 and $3.72, exceeding analyst estimates.

Latest article

These 5 Penny Tech Stocks Are Back in Focus as AI Jitters Hit Nasdaq

These 5 Penny Tech Stocks Are Back in Focus as AI Jitters Hit Nasdaq

29 April 2026
Shares of five U.S.-listed AI penny stocks, including Fabric.AI, Kopin, Blaize, RedCloud, and U-BX Technology, traded below $5 as tech stocks wobbled ahead of major earnings. Fabric.AI announced a $21.5 million private placement and a shift to AI data center infrastructure. Kopin reported a $15 million development order from Fabric.AI. Blaize unveiled a partnership with Nokia and PT Datacomm for AI deployment in Southeast Asia.
Quantum Stocks With Growth Potential in April-May 2026: 4 Names Facing a May Reality Check

Quantum Stocks With Growth Potential in April-May 2026: 4 Names Facing a May Reality Check

29 April 2026
IonQ, Rigetti, and D-Wave will report earnings between May 6 and May 12, with investors watching revenue, bookings, and cash burn. IonQ shares last traded at $43.08, Rigetti at $16.39, D-Wave at $18.11, and Quantum Computing Inc. at $8.57, all with negative price-to-earnings ratios. IonQ announced a quantum-safe network project in Florida. The sector faces pressure from new IPOs and SPACs.
Best Stocks to Buy Today: 5 Earnings Stocks Wall Street Is Watching Before the Fed Decision

Best Stocks to Buy Today: 5 Earnings Stocks Wall Street Is Watching Before the Fed Decision

29 April 2026
Seagate shares jumped 16% in extended trading after forecasting fourth-quarter revenue above estimates and reporting strong third-quarter results. HSBC upgraded U.S. equities to “overweight” following robust earnings, with 84% of reporting companies beating Wall Street forecasts. Bloom Energy raised its 2026 outlook after posting a 130% revenue jump. Coca-Cola lifted its annual profit forecast after beating expectations.
Go toTop